These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1825744)

  • 1. The influence of iris pigmentation on the miotic effect of thymoxamine.
    Diehl DL; Robin AL; Wand M
    Am J Ophthalmol; 1991 Mar; 111(3):351-5. PubMed ID: 1825744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of thymoxamine reversal of phenylephrine-induced mydriasis.
    Wright MM; Skuta GL; Drake MV; Chang LF; Rabbani R; Musch DC; Teikari J
    Arch Ophthalmol; 1990 Dec; 108(12):1729-32. PubMed ID: 2147844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoxamine reverses phenylephrine-induced mydriasis.
    Relf SJ; Gharagozloo NZ; Skuta GL; Alward WL; Anderson DR; Brubaker RF
    Am J Ophthalmol; 1988 Sep; 106(3):251-5. PubMed ID: 2971321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoxamine versus pilocarpine in the reversal of phenylephrine-induced mydriasis.
    Saheb NE; Lorenzetti D; East D; Salpeter-Carlton S
    Can J Ophthalmol; 1982 Dec; 17(6):266-7. PubMed ID: 6219733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thymoxamine eye-drops on the mydriatic effect of tropicamide and phenylephrine alone and in combination.
    Shah B; Hubbard B; Stewart-Jones JH; Edgar DF; Turner P
    Ophthalmic Physiol Opt; 1989 Apr; 9(2):153-5. PubMed ID: 2533678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%.
    Drago F; Dal Bello A; Marino V; Pisati R; Lodola E; Barbieri P
    Eur J Clin Pharmacol; 1993; 44(5):477-80. PubMed ID: 8359186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
    Anicho UM; Cooper J; Feldman J; Jaanus SD; Dignam K
    Optom Vis Sci; 1999 Feb; 76(2):94-101. PubMed ID: 10082055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular thymoxamine or acetylcholine for the reversal of mydriasis.
    Pfeiffer N; Grehn F; Wellek S; Schwenn O
    Ger J Ophthalmol; 1994 Nov; 3(6):422-6. PubMed ID: 7866263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unoprostone isopropyl ester darkens iris color in pigmented rabbits with sympathetic denervation.
    Zhan GL; Toris CB; Meza JL; Camras CB
    J Glaucoma; 2003 Aug; 12(4):383-9. PubMed ID: 12897587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymoxamine on the human pupil.
    Lee DA; Rimele TJ; Brubaker RF; Nagataki S; Vanhoutte PM
    Exp Eye Res; 1983 May; 36(5):655-62. PubMed ID: 6221938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of tropicamide-induced mydriasis by thymoxamine eye drops.
    McKinna H; Stewart-Jones JH; Edgar DF; Turner P
    Curr Med Res Opin; 1988; 11(1):1-3. PubMed ID: 2968223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Doughty MJ; Lyle WM
    Optom Vis Sci; 1992 May; 69(5):358-68. PubMed ID: 1350669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of alpha-adrenergic agents on tonic accommodation.
    Rosenfield M; Gilmartin B; Cunningham E; Dattani N
    Curr Eye Res; 1990 Mar; 9(3):267-72. PubMed ID: 2140763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of alpha-adrenoceptor blockade with thymoxamine on changes in pupil diameter and accommodation produced by tropicamide and ephedrine.
    Mayer GL; Stewart-Jones JH; Turner P
    Curr Med Res Opin; 1977; 4(9):660-4. PubMed ID: 145354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-contact tonometry and pupillary responses to topical phenylephrine and thymoxamine.
    Ramsden RJ; Edgar DF; Stewart-Jones JH; Turner P
    Int J Clin Pharmacol Res; 1985; 5(3):213-4. PubMed ID: 3160674
    [No Abstract]   [Full Text] [Related]  

  • 16. Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration.
    Sandberg MA; Gaudio AR; Miller S; Weiner A
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2734-40. PubMed ID: 7514581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thymoxamine on aqueous humor formation in the normal human eye as measured by fluorophotometry.
    Lee DA; Brubaker RF; Nagataki S
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):805-11. PubMed ID: 6458577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thymoxamine on changes in pupil diameter and accommodation produced by homatropine and ephedrine.
    Small S; Stewart-Jones JH
    Br J Ophthalmol; 1976 Feb; 60(2):132-4. PubMed ID: 131576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymoxamine and angle-closure glaucoma].
    Etienne R
    J Fr Ophtalmol; 1983; 6(12):971-4. PubMed ID: 6232307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pilocarpine, timolol, epifrin and thymoxamine on iris vessels in rhesus monkeys.
    Virdi PS; Hayreh SS
    Int Ophthalmol; 1984 Jan; 7(1):3-10. PubMed ID: 6231261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.